Late sign-ups boost numbers, improve Obamacare outlook
Still to be announced is what share of those 8 million enrollees were previously uninsured, and how many actually secured coverage by paying their first month’s premiums.
Health Care & Life Sciences
Articles
Beck’s Hybrids prospers against far bigger firms
When Lawrence and Francis Beck planted six acres of hybrid corn on their Hamilton County farm almost eight decades ago, the father and son sowed the seeds of a family business that’s still growing despite widespread industry consolidation.
Mainstreet aims to help finance nursing home through crowdfunding
Mainstreet Property Group LLC plans to launch a new round of private placement fundraising on April 21 using a website run by Oregon-based CrowdStreet Inc. and a mix of traditional advertising in central Indiana.
Indiana’s 10 (or more) most profitable health insurers
WellPoint’s commanding market share gave it a whopping $129 million in profit from its risk-based insurance products in 2012. But in percentage terms, WellPoint was not at the top of the heap.
Report: State political leader had millions on the line
Documents show House Speaker Pro Tem Eric Turner earned nearly $8 million selling nursing homes in the last two years and stands to earn between $1 million and $2 million on projects now being developed, thanks in part to legislation he helped block this year.
Insurer acquires Indy-based StreetLinks for $60 million
StreetLinks, which sells real estate appraisal management services and software, will retain its brand name and remain headquartered in Indianapolis, according to the statement.
Leaders await decision on Indiana Plan expansion
Two of the state's top Republican lawmakers said Tuesday that they would like to see the federal government sign off on an expansion of Medicaid through the state's health care plan for low-income residents.
Even without expansion, 40,000 more Hoosiers join Medicaid
The state has not raised the eligibility threshold for Indiana Medicaid, but the program enrolled 40,577 more Hoosiers in March than it did in the same month last year.
Competition, not higher premiums, is biggest threat to Obamacare buyers
For consumers that get tax subsidies in the Obamacare exchanges, out-of-pocket premiums will remain steady even if insurers raise prices next year. But the subsidies could fall if insurers offer lower-cost plans.
Downtown Evansville picked for new IU med school
Evansville officials had pushed the location covering nearly six city blocks as a key for downtown redevelopment. The center that could draw some 2,000 health care students.
ANALYSIS: Turner stood to lose big in Statehouse fight
A top Indiana lawmaker, his family and investors in their company risked losing millions in future profits if a proposed ban on construction of new nursing homes in Indiana had become law this year, an Associated Press review has found.
Health insurers must make educated guesses on 2015 prices
The back-loaded enrollment process for the Obamacare exchanges gives insurers far, far less information about their new customers than usual.
Five things I learned from the Medicare doctor payments
From this week’s historic data dump, I learned who the top 20 recipients of Medicare payments are in Indianapolis (hint: mostly labs, ambulances and eye surgeons). But the real takeaway is that meaningful price information about doctors is still a long way away.
Indiana insurers must make best guesses on 2015 price hikes
Health insurers such as WellPoint Inc. that plan to hike prices on their Obamacare policies more than 10 percent in 2015 will have a much harder time than usual making their case to regulators.
WellPoint spending millions in California ballot battle
WellPoint Inc. is leading companies that have poured $13.4 million into defeating a ballot initiative that would give California regulators the power to reject increases in health policy premiums.
Lilly stock shows little impact from $3B court award
Eli Lilly and Co.’s stock showed little change Tuesday morning in the wake of a federal court decision that saw jurors order the company to pay a massive damage award related to its Actos diabetes medicine.
Ex-owner of troubled dental clinic pleads guilty to tax evasion
The former owner of a central Indiana dental clinic being investigated for Medicaid fraud has been sentenced to two years in federal prison for not paying more than $850,000 in taxes.
Lilly ordered to pay $3 billion in Actos damages
Takeda Pharmaceutical Co. and Eli Lilly and Co. were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
Lilly shares hit all-time high for the John Lechleiter era
Court win last week in a patent challenge to lung cancer drug Alimta pushed Lilly shares higher than they’ve ever been since April 2007. Since then, the company’s pipeline has produced more misfires than the villains in a James Bond movie
Endocyte raises another $100M in stock offering
Another public stock offering by the West Lafayette-based drugmaker swells its war chest for cancer drug development to $225 million.